Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $313.37 | 13 | 96.5% |
| Education | $11.38 | 1 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $126.24 | 4 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $95.41 | 5 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $39.84 | 1 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $32.10 | 2 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $15.87 | 1 | $0 (2023) |
| ITI, Inc. | $15.29 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $196.80 | 8 | Otsuka America Pharmaceutical, Inc. ($69.86) |
| 2023 | $116.57 | 5 | Janssen Pharmaceuticals, Inc ($71.24) |
| 2017 | $11.38 | 1 | Otsuka America Pharmaceutical, Inc. ($11.38) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/19/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Neuroscience | ||||||
| 06/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: PSYCHIATRY | ||||||
| 03/26/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: PSYCHIATRY | ||||||
| 03/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: PSYCHIATRY | ||||||
| 03/07/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $39.84 | General |
| Category: Neuropsychiatry | ||||||
| 02/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: PSYCHIATRY | ||||||
| 02/06/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: PSYCHIATRY | ||||||
| 01/31/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Neuroscience | ||||||
| 12/13/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: PSYCHIATRY | ||||||
| 09/17/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: Neuroscience | ||||||
| 09/06/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: PSYCHIATRY | ||||||
| 07/18/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Neurology | ||||||
| 02/07/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $43.47 | General |
| Category: Neuroscience | ||||||
| 07/18/2017 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Education | In-kind items and services | $11.38 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 396 | 1,953 | $520,960 | $127,634 |
| 2022 | 12 | 575 | 2,119 | $619,033 | $142,216 |
| 2021 | 11 | 554 | 2,664 | $748,234 | $175,481 |
| 2020 | 10 | 530 | 2,067 | $581,747 | $151,321 |
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 60 | 345 | $110,745 | $32,030 | 28.9% |
| 90870 | Therapy using electrical currents | Facility | 2023 | 14 | 314 | $150,720 | $25,996 | 17.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 42 | 610 | $75,640 | $24,156 | 31.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 60 | 345 | $77,280 | $21,446 | 27.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 45 | 49 | $30,086 | $6,371 | 21.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 43 | 78 | $26,052 | $5,765 | 22.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 42 | 49 | $15,925 | $4,335 | 27.2% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Facility | 2023 | 39 | 85 | $17,850 | $3,828 | 21.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 39 | 63 | $14,112 | $2,888 | 20.5% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Facility | 2023 | 12 | 15 | $2,550 | $817.96 | 32.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 92 | 416 | $133,536 | $34,324 | 25.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 102 | 597 | $133,728 | $34,289 | 25.6% |
| 90870 | Therapy using electrical currents | Facility | 2022 | 19 | 340 | $163,200 | $28,979 | 17.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 72 | 78 | $47,892 | $12,253 | 25.6% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 36 | 309 | $38,316 | $9,636 | 25.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 74 | 84 | $27,300 | $7,012 | 25.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Facility | 2022 | 46 | 104 | $21,840 | $4,939 | 22.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 36 | 54 | $12,096 | $2,910 | 24.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 28 | 46 | $16,928 | $2,752 | 16.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 25 | 33 | $11,022 | $2,484 | 22.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 29 | 39 | $9,945 | $1,538 | 15.5% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Facility | 2022 | 16 | 19 | $3,230 | $1,100 | 34.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 107 | 806 | $180,544 | $47,136 | 26.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 88 | 462 | $148,302 | $38,844 | 26.2% |
| 90870 | Shock treatment and monitoring | Facility | 2021 | 21 | 424 | $203,520 | $37,069 | 18.2% |
About Dr. Leonardo Batista, M.D
Dr. Leonardo Batista, M.D is a Psychiatry healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2011. The National Provider Identifier (NPI) number assigned to this provider is 1184919078.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leonardo Batista, M.D has received a total of $324.75 in payments from pharmaceutical and medical device companies, with $196.80 received in 2024. These payments were reported across 14 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($313.37).
As a Medicare-enrolled provider, Batista has provided services to 2,055 Medicare beneficiaries, totaling 8,803 services with total Medicare billing of $596,651. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Providence, RI
- Active Since 06/20/2011
- Last Updated 06/20/2011
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1184919078
Products in Payments
- INVEGA SUSTENNA (Drug) $82.77
- ABILIFY MAINTENA (Drug) $54.84
- CAPLYTA (Drug) $47.39
- SPRAVATO (Drug) $43.47
- REXULTI (Drug) $40.57
- INGREZZA (Drug) $39.84
- UZEDY (Drug) $15.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Providence
Dr. James Greer, Md, MD
Psychiatry — Payments: $727,742
Linda Carpenter, Md, MD
Psychiatry — Payments: $43,650
Brian Ackerman
Psychiatry — Payments: $9,878
Steven Rasmussen, Md, MD
Psychiatry — Payments: $6,302
Kazi Salahuddin, Md, MD
Psychiatry — Payments: $4,840
Katharine Phillips, Md, MD
Psychiatry — Payments: $4,723